Company / SG&A Expense
DarioHealth Corp. SG&A Expense History
FY2014-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$4.7M
FY2018
5-year range
$2.9M / $6.3M
FY2014-FY2018
Trend
+39.9%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $3M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2018 with a 3-year CAGR of +9.1%.
Increased from $3M to $5M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +9.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +9.1%, indicating consistent growth.
- In FY2018, sg&a expense increased 39.9% year-over-year.
- Peak sg&a expense was recorded in FY2014.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $4.7M | +39.9% |
| FY2017 | $3.4M | +14.6% |
| FY2016 | $2.9M | -19.0% |
| FY2015 | $3.6M | -42.2% |
| FY2014 | $6.3M | - |
As of FY2018 · SEC 10-K Annual Filings · Updated Jun 24, 2026